| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | Jun 25, 2024 | Sale | $230.99 | 2,103 | 485,773 | 17,634 | Jun 26, 2024, 04:28 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | Feb 28, 2024 | Sale | $155.30 | 574 | 89,145 | 8,993 | Feb 29, 2024, 04:17 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | Feb 16, 2024 | Sale | $148.06 | 1,308 | 193,666 | 8,160 | Feb 20, 2024, 04:09 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | Aug 04, 2023 | Sale | $185.85 | 3,461 | 643,223 | 11,314 | Aug 07, 2023, 06:05 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | Aug 07, 2023 | Sale | $183.89 | 4,166 | 766,083 | 5,399 | Aug 07, 2023, 06:05 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | Apr 28, 2023 | Sale | $199.02 | 2,455 | 488,595 | 6,596 | Apr 28, 2023, 05:54 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | Apr 27, 2023 | Sale | $194.59 | 1,839 | 357,855 | 8,488 | Apr 28, 2023, 05:54 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | Mar 03, 2023 | Option Exercise | $96.45 | 5,000 | 482,250 | 22,417 | Mar 07, 2023, 04:07 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | Mar 03, 2023 | Sale | $200.00 | 18,072 | 3,614,400 | 4,345 | Mar 07, 2023, 04:07 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | CMO & EVP Dev & Med Affairs | Aug 04, 2022 | Option Exercise | $191.55 | 5,086 | 974,201 | 17,900 | Aug 05, 2022, 04:14 PM |
Menu